kidney pain tirzepatide and prevention of chronic disease Frontiers | Case Report: Rhabdomyolysis

Weight Management Semaglutide was originally approved for the treatment of type 2 diabetes, which means insurance companies are more likely to cover it when prescribed for that purpose

Ann Oncol (2004) 15:1734

Patients receiving tirzepatide showed 55% improvement in sleep apnea symptoms compared to 5% improvement with placebo ^17

Promising effects beyond weight loss Researchers are currently studying the effect of GLP-1s on a wide range of conditions beyond diabetes, obesity, and heart disease, including renal, hepatic, neurological, and substance-use disorders

Recently, it was also approved for treating sleep apnea, a condition linked to severe health risks